This invention relates to dihydropyrimidinones of the formula (I), wherein X and R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.
这项发明涉及公式(I)中的二
氢嘧啶酮,其中X和R1至R7如描述和索赔中定义的那样,以及其药学上可接受的盐。这些化合物是
BACE2抑制剂,可用作治疗或预防疾病如糖尿病的药物。